• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人凝血酶原、因子IX(克里斯马斯因子)、因子X(斯图尔特因子)和蛋白S的比较。

A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

作者信息

Di Scipio R G, Hermodson M A, Yates S G, Davie E W

出版信息

Biochemistry. 1977 Feb 22;16(4):698-706. doi: 10.1021/bi00623a022.

DOI:10.1021/bi00623a022
PMID:836809
Abstract

Human prothrombin, factor IX, and factor X have been idolated in high yield and characterized as the their amino-terminal sequence, molecular weight, amino acid composition, and migration in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. An additional human plasma protein, called protein S, has also been purified and its properties have been compared with those of prothrombin, factor IX, and factor X. Prothrombin (mol wt 72 000), factor IX (mol wt 57 000), and protein S (mol wt 69 000) are single-chain glycoproteins, while factor X (mol wt 59 000) is a glycoprotein composed of two polypeptide chains held together by a disulfide bond(s). The amino-terminal sequence of the light chain of human factor X is homologous with prothrombin, factor IX, and protein S. The heavy chain of human factor X is slightly larger than the heavy chain of bovine factor X and differs from bovine factor X in its amino-terminal sequence.

摘要

人凝血酶原、因子IX和因子X已被高产率分离出来,并对其氨基末端序列、分子量、氨基酸组成以及在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳中的迁移情况进行了表征。另一种人血浆蛋白,称为蛋白S,也已被纯化,并将其性质与凝血酶原、因子IX和因子X的性质进行了比较。凝血酶原(分子量72000)、因子IX(分子量57000)和蛋白S(分子量69000)是单链糖蛋白,而因子X(分子量59000)是由通过二硫键连接在一起的两条多肽链组成的糖蛋白。人因子X轻链的氨基末端序列与凝血酶原、因子IX和蛋白S同源。人因子X的重链比牛因子X的重链略大,并且在氨基末端序列上与牛因子X不同。

相似文献

1
A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.人凝血酶原、因子IX(克里斯马斯因子)、因子X(斯图尔特因子)和蛋白S的比较。
Biochemistry. 1977 Feb 22;16(4):698-706. doi: 10.1021/bi00623a022.
2
A comparison of bovine prothrombin, factor IX (Christmas factor), and factor X (Stuart factor).牛凝血酶原、因子IX(克里斯马斯因子)和因子X(斯图尔特因子)的比较。
Proc Natl Acad Sci U S A. 1974 Feb;71(2):427-30. doi: 10.1073/pnas.71.2.427.
3
Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography.
Thromb Res. 1989 Jul 1;55(1):121-33. doi: 10.1016/0049-3848(89)90462-3.
4
Factor X activating enzyme from Russell's viper venom: isolation and characterization.来自锯鳞蝰蛇毒的X因子激活酶:分离与特性鉴定。
Biochemistry. 1976 Nov 2;15(22):4901-6. doi: 10.1021/bi00667a023.
5
Bovine factor IX (Christmas factor). Further evidence of homology with factor X (Stuart factor) and prothrombin.牛凝血因子IX(克里斯马斯因子)。与凝血因子X(斯图尔特因子)和凝血酶原同源性的进一步证据。
FEBS Lett. 1974 Oct 1;47(1):132-5. doi: 10.1016/0014-5793(74)80442-4.
6
A method for systematic purification from bovine plasma of six vitamin K-dependent coagulation factors: prothrombin, factor X, factor IX, protein S, protein C, and protein Z.
J Biochem. 1985 May;97(5):1347-55. doi: 10.1093/oxfordjournals.jbchem.a135187.
7
A simplified procedure for purification of human prothrombin, factor IX and factor X.一种纯化人凝血酶原、因子IX和因子X的简化程序。
Prep Biochem. 1981;11(4):397-412. doi: 10.1080/00327488108065531.
8
Human prothrombin activation.
J Biol Chem. 1975 Dec 10;250(23):8897-906.
9
Comparison of amino acid sequence of bovine coagulation Factor IX (Christmas Factor) with that of other vitamin K-dependent plasma proteins.牛凝血因子IX(克里斯马斯因子)与其他维生素K依赖血浆蛋白的氨基酸序列比较。
Proc Natl Acad Sci U S A. 1979 Oct;76(10):4990-4. doi: 10.1073/pnas.76.10.4990.
10
Vitamin K-dependent plasma proteins.维生素K依赖的血浆蛋白
Methods Enzymol. 1984;107:507-16. doi: 10.1016/0076-6879(84)07035-x.

引用本文的文献

1
Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway.关于PROS1通过AKT/GSK3β/β-连环蛋白途径抑制膀胱癌进展和血管生成的机制性见解。
Sci Rep. 2025 Feb 8;15(1):4748. doi: 10.1038/s41598-025-89217-4.
2
Role and Mechanisms of Tyro3 in Podocyte Biology and Glomerular Disease.酪氨酸激酶3(Tyro3)在足细胞生物学和肾小球疾病中的作用及机制
Kidney Dis (Basel). 2024 Jul 24;10(5):398-406. doi: 10.1159/000540452. eCollection 2024 Oct.
3
Coagulation Factor Xa Has No Effects on the Expression of PAR1, PAR2, and PAR4 and No Proinflammatory Effects on HL-1 Cells.
凝血因子Xa对PAR1、PAR2和PAR4的表达无影响,对HL-1细胞无促炎作用。
Cells. 2023 Dec 15;12(24):2849. doi: 10.3390/cells12242849.
4
The Pathophysiology and Management of Hemorrhagic Shock in the Polytrauma Patient.多发伤患者失血性休克的病理生理学与处理
J Clin Med. 2021 Oct 19;10(20):4793. doi: 10.3390/jcm10204793.
5
Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics.凝血因子 X:分子生物学、遗传性疾病与工程治疗学。
J Thromb Thrombolysis. 2021 Aug;52(2):383-390. doi: 10.1007/s11239-021-02456-w. Epub 2021 Apr 22.
6
Zika Virus Pathogenesis: A Battle for Immune Evasion.寨卡病毒发病机制:一场免疫逃逸之战。
Vaccines (Basel). 2021 Mar 22;9(3):294. doi: 10.3390/vaccines9030294.
7
Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity.血小板靶向高功能 FIX 基因治疗血友病 B 小鼠,即使存在抗 FIX 免疫。
Blood Adv. 2021 Mar 9;5(5):1224-1238. doi: 10.1182/bloodadvances.2020004071.
8
Activated protein C has a regulatory role in factor VIII function.活化蛋白 C 在因子 VIII 功能中具有调节作用。
Blood. 2021 May 6;137(18):2532-2543. doi: 10.1182/blood.2020007562.
9
Proteomics-Based Identification of Diagnostic Biomarkers Related to Risk Factors and Pathogenesis of Ischemic Stroke.基于蛋白质组学鉴定与缺血性中风危险因素及发病机制相关的诊断生物标志物
Diagnostics (Basel). 2020 May 25;10(5):340. doi: 10.3390/diagnostics10050340.
10
Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.血小板蛋白 S 通过控制血栓中的凝血来限制静脉血栓形成倾向,但不限制动脉血栓形成倾向。
Blood. 2020 May 28;135(22):1969-1982. doi: 10.1182/blood.2019003630.